The University of Chicago Header Logo

Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study.

Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study. Invest New Drugs. 1994; 12(4):345-6.

View in: PubMed